Literature DB >> 34331180

Butylcycloheptylprodigiosin and undecylprodigiosin are potential photosensitizer candidates for photodynamic cancer therapy.

Zahra Arshadi1, Sayedeh Azimeh Hosseini1, Daryoush Fatehi2, Seyed Abbas Mirzaei1, Fatemeh Elahian3,4.   

Abstract

BACKGROUND: Prodiginines are bacterial red polypyrrole pigments and multifaceted secondary metabolites. These agents have anti-proliferative, immunosuppressive, antimicrobial, and anticancer effects. Recent analysis revealed that prodigiosin hypersensitizes Serratia marcescens to gamma radiation. In the present study, we report the cytotoxicity and genotoxicity properties of undecylprodigiosin and butylcycloheptylprodigiosin in the presence and absence of radiation through the MTT and alkaline comet experiments. METHODS AND
RESULTS: Findings demonstrated that undecylprodigiosin was at least a fivefold more cytotoxic at low radiation doses (1 and 3 Gy) on both MCF7 and HDF lines rather than in the absence or high radiation doses (5 Gy) (P value < 0.05). Although butylcycloheptylprodigiosin toxicity on MCF7 and HDF was dose-dependent, it was not influenced by any radiation doses (P value > 0.05). Comet findings confirmed that these compounds' genotoxicity is only dose-dependent. Radiation had no significant effects on DNA damage on any of the cells (P value > 0.05).
CONCLUSIONS: In general, it can be concluded that the prodiginines are cytotoxic agents that act as a double-edged sword, radiosensitizers and radio-protective, respectively at low and high radiation doses in cancer treatment process. As the results they could be used in antitumor therapies very soon.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Butylcycloheptylprodigiosin; Cytotoxicity; Genotoxicity; HDF cell; MCF7 cell; Radiotherapy; Undecylprodigiosin

Mesh:

Substances:

Year:  2021        PMID: 34331180     DOI: 10.1007/s11033-021-06598-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

Review 1.  Photodynamic therapy - mechanisms, photosensitizers and combinations.

Authors:  Stanisław Kwiatkowski; Bartosz Knap; Dawid Przystupski; Jolanta Saczko; Ewa Kędzierska; Karolina Knap-Czop; Jolanta Kotlińska; Olga Michel; Krzysztof Kotowski; Julita Kulbacka
Journal:  Biomed Pharmacother       Date:  2018-07-17       Impact factor: 6.529

2.  The anticancer agent prodigiosin is not a multidrug resistance protein substrate.

Authors:  Fatemeh Elahian; Bahareh Moghimi; Farideh Dinmohammadi; Mahsa Ghamghami; Mehrdad Hamidi; Seyed Abbas Mirzaei
Journal:  DNA Cell Biol       Date:  2013-02-01       Impact factor: 3.311

3.  The impact of concentration and administration time on the radiomodulating properties of undecylprodigiosin in vitro.

Authors:  Sandra Petrović; Vesna Vasić; Tatjana Mitrović; Saša Lazović; Andreja Leskovac
Journal:  Arh Hig Rada Toksikol       Date:  2017-03-01       Impact factor: 1.948

4.  Assaying DNA damage in hippocampal neurons using the comet assay.

Authors:  Somaira Nowsheen; Fen Xia; Eddy S Yang
Journal:  J Vis Exp       Date:  2012-12-19       Impact factor: 1.355

5.  Unlike Butylcycloheptylprodigiosin, Isolated Undecylprodigiosin from Streptomyces parvulus Is Not a MDR1 and BCRP Substrate in Multidrug-Resistant Cancers.

Authors:  Seyed Abbas Mirzaei; Mansureh Safari Kavishahi; Zhila Keshavarz; Fatemeh Elahian
Journal:  DNA Cell Biol       Date:  2018-04-19       Impact factor: 3.311

6.  Differential genomic damage in different tumor lines induced by prodigiosin.

Authors:  Jeanne Cristina Lapenda Lins; Maria Eliane Bezerra DE Melo; Silene Carneiro DO Nascimento; Monica Lucia Adam
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

Review 7.  Prodigiosin and its potential applications.

Authors:  N Darshan; H K Manonmani
Journal:  J Food Sci Technol       Date:  2015-01-24       Impact factor: 2.701

Review 8.  Cancer and radiation therapy: current advances and future directions.

Authors:  Rajamanickam Baskar; Kuo Ann Lee; Richard Yeo; Kheng-Wei Yeoh
Journal:  Int J Med Sci       Date:  2012-02-27       Impact factor: 3.738

9.  Polymorphism of rs1836882 in NOX4 gene modifies associations between dietary caloric intake and ROS levels in peripheral blood mononuclear cells.

Authors:  Qiang Liu; Hong Li; Ningfu Wang; Huaihong Chen; Qihui Jin; Ruoyu Zhang; Jing Wang; Ying Chen
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  Gene delivery potential of biofunctional carbonate apatite nanoparticles in lungs.

Authors:  Suleiman Yusuf Alhaji; Ezharul Houque Chowdhury; Rozita Rosli; Fatma Hassan; Syahril Abdullah
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.